12:01 :
Meridian Bioscience tumbles 16% on forecast -
BOSTON (MarketWatch) -- Shares of Meridian Bioscience tumbled 16% to $22.99 on Thursday after the diagnostic-testing company lowered its financial forecast. Meridian said it now sees 2011 revenue coming in between $160 million ...